Five years ago, vivo introduced OriginOS, its next generation OS that was set to replace FuntouchOS – and it did, but only in China. Until now. As you may have heard, OriginOS is going global. This is ...

Vivo is gearing up to bring its latest flagship smartphones, Vivo X300 Pro and Vivo X300, to India soon. Both handsets, which made their debut in China earlier this month, have now been spotted on the ...

Tech giant Vivo has announced the rollout timeline for its latest Android 16-based OriginOS 6 update in India. The update, which was rolled out in China on 10 October 2025, will begin rolling out to ...

The vivo X300 Pro brings subtle improvements to the already solid camera system of its predecessor. At the same time vivo has taken care not to disrupt the X200 Ultra as the all-out camera flagship of ...

The Vivo X300 series is making its debut tomorrow as the first Android flagship to feature the MediaTek Dimensity 9500 SoC. To recall, MediaTek's flagship chip was unveiled back in September to ...

Gabi Moura has been manifesting walking in the Victoria’s Secret Fashion Show forever (she even dressed as a VS Angel last Halloween). She just didn’t think it would ever actually happen. She got the ...

It is an all-too-common scenario—a baby is up all night crying, and an exhausted mother gets in and out of bed to care for the infant. The father sleeps soundly next to her, seemingly oblivious to the ...

Hazel Park’s Bar Gabi focuses on Romanian cuisine. Credit: Mark Kurlyandchik / Booth One Creative A new restaurant concept with a focus on Romanian cuisine is ready to serve in Hazel Park’s former ...

Vivo has just unveiled its X300 series in China, comprising the standard X300 and the X300 Pro. The handsets pack MediaTek’s latest Dimensity 9500 SoC, ZEISS-tuned rear camera setup and V3+ image ...

Vivo is finally bringing OriginOS 6 — its next big Android 16-based update — to users outside China. The global debut, including India, is confirmed for October 15, marking the official end of ...

Gilead Sciences' Kite Pharma is doubling down on in vivo CAR-T, this time inking a deal worth up to $1.64 billion biobucks with Chinese biotech Pregene Biopharma. Kite has paid out $120 million ...